IN2014DN09962A - - Google Patents
Info
- Publication number
- IN2014DN09962A IN2014DN09962A IN9962DEN2014A IN2014DN09962A IN 2014DN09962 A IN2014DN09962 A IN 2014DN09962A IN 9962DEN2014 A IN9962DEN2014 A IN 9962DEN2014A IN 2014DN09962 A IN2014DN09962 A IN 2014DN09962A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261653913P | 2012-05-31 | 2012-05-31 | |
| PCT/SG2013/000031 WO2013180647A1 (en) | 2012-05-31 | 2013-01-21 | Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09962A true IN2014DN09962A (en) | 2015-08-14 |
Family
ID=49673718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9962DEN2014 IN2014DN09962A (en) | 2012-05-31 | 2014-11-25 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9890205B2 (en) |
| EP (1) | EP2855504B1 (en) |
| JP (1) | JP6297029B2 (en) |
| KR (1) | KR20150027060A (en) |
| CN (1) | CN104507955A (en) |
| IN (1) | IN2014DN09962A (en) |
| SG (1) | SG11201407809QA (en) |
| WO (1) | WO2013180647A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015519361A (en) * | 2012-05-31 | 2015-07-09 | エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ | Method for reducing the level of protein-impurity complexes and aggregates in protein formulations by treatment with positively charged organic additives |
| SG11201505202SA (en) * | 2013-02-22 | 2015-08-28 | Agency Science Tech & Res | Materials and methods for removing endotoxins from protein preparations |
| EP2961761B1 (en) * | 2013-02-28 | 2018-09-12 | Agency For Science, Technology And Research | Protein purification in the presence of nonionic organic polymers at elevated conductivity |
| JP2017507938A (en) * | 2014-02-19 | 2017-03-23 | エイジェンシー・フォー・サイエンス，テクノロジー・アンド・リサーチ | Classification method |
| KR20160127087A (en) * | 2014-02-27 | 2016-11-02 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | Methods for reducing chromatin content in protein preparations by treatment with alkyl cations |
| US10160784B2 (en) | 2014-02-27 | 2018-12-25 | Agency For Science, Technology And Research | Antibody purification process |
| EP3674310A1 (en) * | 2014-03-10 | 2020-07-01 | Richter Gedeon Nyrt. | Immunoglobulin purification using pre-cleaning steps |
| WO2015183183A1 (en) * | 2014-05-29 | 2015-12-03 | Agency For Science, Technology And Research | Protein Extraction Methods |
| CN104356211B (en) * | 2014-09-22 | 2017-08-29 | 山东信得科技股份有限公司 | One kind application Triton X 114 and allantoin remove endotoxic method in recombinant protein solution |
| JP6824555B2 (en) * | 2015-03-31 | 2021-02-03 | サイティバ・スウェーデン・アクチボラグ | Liquid chromatography systems, equipment, and methods |
| US11697800B2 (en) | 2015-11-05 | 2023-07-11 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. | Method for the separation of virus compositions including depletion and purification thereof |
| US20190039046A1 (en) * | 2016-02-25 | 2019-02-07 | Hitachi, Ltd. | Adsorbent material and purification method |
| CN109964123A (en) * | 2016-11-18 | 2019-07-02 | 捷恩智株式会社 | The purification process of antibody |
| WO2018147393A1 (en) * | 2017-02-10 | 2018-08-16 | 三菱ケミカル株式会社 | Separating agent for human insulin purification and human insulin purification method |
| US20210024573A1 (en) * | 2018-04-03 | 2021-01-28 | Merck Patent Gmbh | Cex chromatography media and low salt elution of target proteins from biopharmaceutical feeds |
| WO2021044029A1 (en) | 2019-09-06 | 2021-03-11 | Bia Separations D.O.O. | Compositions and methods for reducing chromatin content of biological preparations |
| JP2023523823A (en) | 2020-05-01 | 2023-06-07 | カシーヴ バイオサイエンシズ，リミテッド・ライアビリティ・カンパニー | Improved process of protein purification |
| AU2021265346A1 (en) * | 2020-05-01 | 2022-12-22 | Kashiv Biosciences, Llc | An improved process of affinity chromatography |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0666793A (en) * | 1984-09-14 | 1994-03-11 | Medekusu:Kk | Antibody specific to protein only appearing from rheumatism |
| US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
| US5691132A (en) | 1994-11-14 | 1997-11-25 | Cerus Corporation | Method for inactivating pathogens in red cell compositions using quinacrine mustard |
| DK1084147T3 (en) * | 1998-06-09 | 2004-10-25 | Statens Seruminstitut | Process for preparing immunoglobulins for administration and other immunoglobulin products |
| ATE327033T1 (en) | 1999-07-30 | 2006-06-15 | Genentech Inc | CHARGED FILTRATION MEMBRANES AND USES THEREOF |
| GB0216002D0 (en) * | 2002-07-10 | 2002-08-21 | Nat Blood Authority | Process and composition |
| CA2548220A1 (en) * | 2003-12-01 | 2005-09-09 | Introgen Therapeutics, Inc. | Use of mda-7 to inhibit infection by pathogenic organisms |
| JP2008500959A (en) * | 2004-01-30 | 2008-01-17 | スオメン プナイネン リスティ ヴェリパルヴェル | Immunoglobulin production method safe for viruses |
| EP1718675B2 (en) * | 2004-02-27 | 2017-01-25 | Octapharma AG | A method of providing a purified, virus safe antibody preparation |
| AU2005299716B2 (en) * | 2004-10-22 | 2012-09-06 | Amgen Inc. | Methods for refolding of recombinant antibodies |
| ATE476501T1 (en) * | 2005-01-14 | 2010-08-15 | Bayer Healthcare Llc | PROCEDURE FOR PURIFYING FACTOR VII |
| MX2007011129A (en) * | 2005-03-11 | 2007-11-06 | Wyeth Corp | A method of weak partitioning chromatography. |
| NZ611859A (en) * | 2006-04-05 | 2014-12-24 | Abbvie Biotechnology Ltd | Antibody purification |
| WO2007136327A1 (en) | 2006-05-22 | 2007-11-29 | Ge Healthcare Bio-Sciences Ab | A method of producing igg |
| JP2010510963A (en) * | 2006-06-14 | 2010-04-08 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | Antibody purification method using ceramic hydroxyapatite |
| BRPI0806367A2 (en) | 2007-01-22 | 2011-09-06 | Genentech Inc | antibody purification methods |
| CN101306200B (en) * | 2008-07-04 | 2011-04-06 | 四川远大蜀阳药业股份有限公司 | Preparation method of hepatitis b human immunoglobulin for intravenous injection |
| US20110144311A1 (en) * | 2008-08-14 | 2011-06-16 | Rebecca Chmielowski | Methods for purifying antibodies using protein a affinity chromatography |
| MX2011004199A (en) * | 2008-10-20 | 2011-05-24 | Abbott Lab | Antibodies that bind to il-18 and methods of purifying the same. |
| US20120282654A1 (en) * | 2009-04-29 | 2012-11-08 | Schering Corporation | Antibody purification |
| IT1397061B1 (en) * | 2009-12-28 | 2012-12-28 | Kedrion Spa | NEW PROCESS OF PURIFICATION ON INDUSTRIAL SCALE OF GAMMAGLOBULINE FROM HUMAN PLASMA FOR INDUSTRIAL USE. |
| WO2011088030A1 (en) * | 2010-01-15 | 2011-07-21 | Bryan William Jones | Disease diagnosis and treatment using computational molecular phenotyping |
| GB201012599D0 (en) * | 2010-07-27 | 2010-09-08 | Ucb Pharma Sa | Process for purifying proteins |
| JP6061853B2 (en) * | 2010-07-30 | 2017-01-18 | メディミューン，エルエルシー | Method for purifying active polypeptide or immune complex |
| WO2012054679A1 (en) * | 2010-10-20 | 2012-04-26 | Medimmune, Llc | Methods for processing inclusion bodies |
| CN102286099B (en) * | 2011-08-05 | 2014-04-09 | 深圳市卫光生物制品股份有限公司 | Human cytomegalovirus immunoglobulin for intravenous injection and preparation method thereof |
| SG11201505202SA (en) * | 2013-02-22 | 2015-08-28 | Agency Science Tech & Res | Materials and methods for removing endotoxins from protein preparations |
| SG11201505192RA (en) * | 2013-02-28 | 2015-08-28 | Agency Science Tech & Res | Chromatographic purification of antibodies from chromatin-deficient cell culture harvests |
| US10174076B2 (en) * | 2013-06-04 | 2019-01-08 | Agency For Science, Technology And Research | Protein purification process |
-
2013
- 2013-01-21 CN CN201380040418.9A patent/CN104507955A/en active Pending
- 2013-01-21 EP EP13797544.7A patent/EP2855504B1/en not_active Not-in-force
- 2013-01-21 WO PCT/SG2013/000031 patent/WO2013180647A1/en not_active Ceased
- 2013-01-21 JP JP2015514962A patent/JP6297029B2/en not_active Expired - Fee Related
- 2013-01-21 SG SG11201407809QA patent/SG11201407809QA/en unknown
- 2013-01-21 KR KR1020147033090A patent/KR20150027060A/en not_active Abandoned
-
2014
- 2014-11-25 IN IN9962DEN2014 patent/IN2014DN09962A/en unknown
- 2014-11-26 US US14/555,060 patent/US9890205B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN104507955A (en) | 2015-04-08 |
| US20150183852A1 (en) | 2015-07-02 |
| EP2855504A4 (en) | 2015-07-29 |
| SG11201407809QA (en) | 2014-12-30 |
| US9890205B2 (en) | 2018-02-13 |
| KR20150027060A (en) | 2015-03-11 |
| JP6297029B2 (en) | 2018-03-20 |
| WO2013180647A1 (en) | 2013-12-05 |
| JP2015519360A (en) | 2015-07-09 |
| EP2855504A1 (en) | 2015-04-08 |
| EP2855504B1 (en) | 2018-10-24 |